Only 1% of your DNA makes you different from every other person alive. That 1% may already know what's coming for you.
Gert Van Wyk ran a fund at one of South Africa's largest financial institutions. Then a close friend — fit, ripped, a father of three — died at 40. He closed the fund and started Biocertica, a biotechnology company built on a simple transfer of logic: we manage financial risk every single day, so why do we only manage health risk after something has already gone wrong?
In this conversation with Mpho Dagada, he breaks down what's actually knowable about your body before symptoms appear, why the wrong medication is one of the leading precursors of death in hospital settings, and why almost every drug study behind your prescription was conducted on European bodies — leaving a genetic data gap that affects which medicines work in Africa.
If you've ever wondered whether the disease in your family is inevitable, this is the episode.
TIMESTAMPS
00:00 — Intro
02:00 — What Biocertica actually does
03:50 — How long are we supposed to live?
05:00 — Is there a fountain of youth?
06:23 — Intrinsic risk and what you're predisposed to
07:22 — Genetics is a photo, blood tests are a video
07:45 — Wearables as the cheapest way in
08:52 — The interventions that have saved lives
10:20 — Why people only get reactive after the fact
11:06 — "Pharmaceuticals are not going to like you"
11:41 — A dad with hypertension at 60: what can be done?
14:38 — Pharmacogenetics explained
15:57 — Why the same drug works differently in different bodies
16:53 — Africa's genetic data gap
17:24 — Migration, gene pools and why the gap exists
18:39 — Only 1% of DNA makes the difference
19:11 — The friend who died at 40
21:00 — The most shocking thing about healthcare
22:08 — AI, data, and questions you'd never ask your doctor
24:15 — Why a recommendation is a dead thing
25:06 — Buying back your life
26:51 — Funding, and where the money's personality fits
29:54 — Who the client actually is
30:46 — What you get on the platform
32:14 — How many diseases are unnecessary?
33:57 — Peptides and GLP-1s: what's real
35:39 — What's next for Biocertica
37:25 — Legacy
IN THIS EPISODE
→ Why being born is itself a risk exposure, and what you can do about it
→ The difference between a genetic predisposition and a diagnosis
→ How wearables, blood tests and DNA fit together into one picture
→ Why the wrong medicine harms patients even when the doctor does everything right
→ What pharmacogenetics is, and how it selects the right chemotherapy
→ Why African genetic data matters for which drugs get prescribed here
→ The medical aid buckets most people don't know they can use
→ What to be careful about before buying peptides
→ Why measuring your health is easy and acting on it isn't
ABOUT THE GUEST
Gert Van Wyk is the founder and CEO of Biocertica, a South African biotechnology company operating at the intersection of genomics, preventative health and secure data. Formerly a fund manager, he now builds health intelligence infrastructure across South Africa, Kenya, the UAE and the US.
ABOUT FOR THIS REASON
For This Reason is hosted by Mpho Dagada — founder of MRD FutureTech — with conversations on business, technology, health and the systems shaping Africa's future.
This conversation is for general information and is not medical advice. Speak to a qualified healthcare practitioner before making decisions about your health, medication or testing.
#MphoDagada
Disclaimer: I do not accept any liability for any loss or damage incurred from you acting or not acting as a result of watching any of my publications. You acknowledge that you use the information I provide at your own risk. Do your research.
from Mpho Dagada Network https://www.youtube.com/watch?v=ue3AmgV5uTM
No comments:
Post a Comment